BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

891 related articles for article (PubMed ID: 11858489)

  • 1. Bothrojaracin, a proexosite I ligand, inhibits factor Va-accelerated prothrombin activation.
    Monteiro RQ; Zingali RB
    Thromb Haemost; 2002 Feb; 87(2):288-93. PubMed ID: 11858489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of prothrombin activation by bothrojaracin, a C-type lectin from Bothrops jararaca venom.
    Monteiro RQ; Zingali RB
    Arch Biochem Biophys; 2000 Oct; 382(1):123-8. PubMed ID: 11051105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of thrombin-catalyzed factor V activation by bothrojaracin.
    Arocas V; Lemaire C; Bouton MC; Bezeaud A; Bon C; Guillin MC; Jandrot-Perrus M
    Thromb Haemost; 1998 Jun; 79(6):1157-61. PubMed ID: 9657441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of the prothrombin fragment 2 domain to the function of factor Va in the prothrombinase complex.
    Krishnaswamy S; Walker RK
    Biochemistry; 1997 Mar; 36(11):3319-30. PubMed ID: 9116010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assembly and regulation of prothrombinase complex on B16F10 melanoma cells.
    Kirszberg C; Rumjanek VM; Monteiro RQ
    Thromb Res; 2005; 115(1-2):123-9. PubMed ID: 15567463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of bothrojaracin with prothrombin.
    Zingali RB; Bianconi ML; Monteiro RQ
    Haemostasis; 2001; 31(3-6):273-8. PubMed ID: 11910195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteolysis of factor V by cathepsin G and elastase indicates that cleavage at Arg1545 optimizes cofactor function by facilitating factor Xa binding.
    Camire RM; Kalafatis M; Tracy PB
    Biochemistry; 1998 Aug; 37(34):11896-906. PubMed ID: 9718313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bothrojaracin: a potent two-site-directed thrombin inhibitor.
    Arocas V; Zingali RB; Guillin MC; Bon C; Jandrot-Perrus M
    Biochemistry; 1996 Jul; 35(28):9083-9. PubMed ID: 8703912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of bothrojaracin interaction with human prothrombin.
    Monteiro RQ; Bock PE; Bianconi ML; Zingali RB
    Protein Sci; 2001 Sep; 10(9):1897-904. PubMed ID: 11514680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exosites determine macromolecular substrate recognition by prothrombinase.
    Krishnaswamy S; Betz A
    Biochemistry; 1997 Oct; 36(40):12080-6. PubMed ID: 9315846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficient thrombin generation requires molecular phosphatidylserine, not a membrane surface.
    Majumder R; Weinreb G; Lentz BR
    Biochemistry; 2005 Dec; 44(51):16998-7006. PubMed ID: 16363813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Membrane-dependent interaction of factor Xa and prothrombin with factor Va in the prothrombinase complex.
    Qureshi SH; Yang L; Manithody C; Rezaie AR
    Biochemistry; 2009 Jun; 48(22):5034-41. PubMed ID: 19378973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition by human thrombomodulin of factor Xa-mediated cleavage of prothrombin.
    Thompson EA; Salem HH
    J Clin Invest; 1986 Jul; 78(1):13-7. PubMed ID: 3013935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The intriguing world of prothrombin activators from snake venom.
    Kini RM
    Toxicon; 2005 Jun; 45(8):1133-45. PubMed ID: 15922779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The interaction of fragment 1 of prothrombin with the membrane surface is a prerequisite for optimum expression of factor Va cofactor activity within prothrombinase.
    Bukys MA; Orban T; Kim PY; Nesheim ME; Kalafatis M
    Thromb Haemost; 2008 Mar; 99(3):511-22. PubMed ID: 18327399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetics of human factor VII activation.
    Butenas S; Mann KG
    Biochemistry; 1996 Feb; 35(6):1904-10. PubMed ID: 8639673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allosteric changes of thrombin catalytic site induced by interaction of bothrojaracin with anion-binding exosites I and II.
    Monteiro RQ; Rapôso JG; Wisner A; Guimarães JA; Bon C; Zingali RB
    Biochem Biophys Res Commun; 1999 Sep; 262(3):819-22. PubMed ID: 10471408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human factor Va1 and factor Va2: properties in the procoagulant and anticoagulant pathways.
    Hoekema L; Nicolaes GA; Hemker HC; Tans G; Rosing J
    Biochemistry; 1997 Mar; 36(11):3331-5. PubMed ID: 9116011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective inhibition of the prothrombinase complex: factor Va alters macromolecular recognition of a tick anticoagulant peptide mutant by factor Xa.
    Betz A; Vlasuk GP; Bergum PW; Krishnaswamy S
    Biochemistry; 1997 Jan; 36(1):181-91. PubMed ID: 8993332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In the presence of phospholipids, glycosaminoglycans potentiate factor Xa-mediated protein C activation by modulating factor Xa activity.
    McRae SJ; Stafford AR; Fredenburgh JC; Weitz JI
    Biochemistry; 2007 Apr; 46(13):4195-203. PubMed ID: 17343367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.